On the expression of fractalkine by rosiglitazone in human renal mesangial cells induced by advanced glycation end products / 中华内分泌代谢杂志
Chinese Journal of Endocrinology and Metabolism
; (12): 660-661, 2008.
Artículo
en Chino
| WPRIM (Pacífico Occidental)
| ID: wpr-397356
Biblioteca responsable:
WPRO
ABSTRACT
The effect of rosiglitazone and advanced glycation end products (AGEs) on the expression of fractalkine in cultured human renal mesangial cells (HRMC) were investigated. Rosiglitazone inhibits the upregulation of fractalkine induced by AGEs in HRMC.
Texto completo:
Disponible
Base de datos:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Chinese Journal of Endocrinology and Metabolism
Año:
2008
Tipo del documento:
Artículo
